A leucine zipper-based peptide hybrid system delivered functional Nanog protein into cell nuclei by using charge-complementary peptide pairs — one attached to a cell-penetrating peptide, the other to the protein cargo.
Functional nuclear protein delivery achievedNanog protein delivered via the leucine zipper-CPP system not only reached the cell nucleus but retained its transcriptional activity — proving the delivery method preserves cargo function.
What the researchers found
A pair of leucine zipper-based compounds was synthesized: Lz(E)-CPP (negatively charged zipper + cell-penetrating peptide) and Nanog-Lz(K) (positively charged zipper + cargo protein). When mixed at equimolar concentrations and applied to cells, the Nanog-Lz(K)/Lz(E)-CPP hybrid was successfully delivered into cells. Nanog protein reached the nucleus and exerted its proper transcriptional function after nuclear transport — demonstrating that the delivery system preserved protein activity.
Why it matters
Intracellular protein delivery is the holy grail of protein therapeutics — most therapeutic proteins can't cross cell membranes. This modular system is elegant because it separates the delivery mechanism (CPP) from the cargo (protein) using a universal leucine zipper 'adapter.' This means any protein could potentially be delivered by simply attaching Lz(K) to it, without redesigning the delivery vehicle each time. The fact that nuclear delivery preserves function is particularly important for transcription factor therapies.
How the study worked
Researchers chemically synthesized two complementary leucine zipper peptides: Lz(E) containing negatively charged residues and Lz(K) containing positively charged residues. Lz(E) was conjugated to a cell-penetrating peptide. Lz(K) was fused to recombinant Nanog protein. The components were mixed at equimolar ratios and applied to HeLa cells. Cellular uptake and nuclear localization were assessed, and Nanog's transcriptional function was confirmed.
What this study cannot tell us
Very brief communication with limited experimental detail. Only one protein cargo (Nanog) was tested — generalizability to other proteins is assumed but not demonstrated. Only HeLa cells were used. Delivery efficiency (percentage of cells successfully transfected) was not quantified. Stability of the leucine zipper complex in serum or in vivo was not assessed. No comparison to other protein delivery methods was made. The study used a stem cell transcription factor as cargo, raising questions about safety if delivered to non-stem cells.
How to read the evidence
This is a proof-of-concept study published as a brief communication. While the concept is demonstrated convincingly for one protein in one cell type, the experimental scope is limited. No quantitative efficiency data, stability studies, or comparison to alternative methods are provided.
When this study was published
Published in 2019, this study introduced a modular peptide-based protein delivery concept that adds to the growing toolkit for intracellular biologics delivery.
The bigger picture
Protein therapeutics are limited by the cell membrane barrier — most biologics work only on cell surface targets. This leucine zipper delivery system joins a growing toolkit of peptide-based intracellular delivery methods (CPPs, stapled peptides, etc.) that could eventually enable proteins to reach any cellular compartment. The modular 'plug-and-play' design is particularly attractive for clinical translation, as the CPP-zipper component could serve as a universal delivery platform.
Questions still open
- Can this leucine zipper delivery system work with larger or more complex protein cargoes beyond Nanog?
- What percentage of cells receive functional nuclear protein, and how does efficiency compare to electroporation or viral delivery?
- Would the leucine zipper complex remain stable during in vivo circulation, or would it dissociate before reaching target cells?
Common questions
How does the leucine zipper system deliver proteins inside cells?
Why is nuclear protein delivery important?
Read the original research
A leucine zipper-based peptide hybrid delivers functional Nanog protein inside the cell nucleus.
Bioorganic & medicinal chemistry letters, 29(7), 878-881
Citation
Hakata, Yoshiyuki; Michiue, Hiroyuki; Ohtsuki, Takashi; Miyazawa, Masaaki; Kitamatsu, Mizuki. (2019). A leucine zipper-based peptide hybrid delivers functional Nanog protein inside the cell nucleus.. Bioorganic & medicinal chemistry letters, 29(7), 878-881. https://doi.org/10.1016/j.bmcl.2019.02.004